CLINICAL STUDY OF APPRAISAL OF THE EFFECTIVENESS OF 1,25 (OH)2D3 (CALCITRIOL) TOWARDS PLACEBO IN THE DIABETES OF TYPE 1 OF RECENET INSORGENCE (IMDIAB XIII)

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-000751-15-IT

Enrollment

Registered

2005-07-25

Start date

2005-10-01

Completion date

Unknown

Last updated

2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GLICOMETABOLIC CONTROL AND ENDOGENOUS INSULIN SECRETION MedDRA version: 6.1 Level: PT Classification code 10012601

Interventions

Trade Name: ROCALTROL*0,25MCG 30CPS Product Name: NA Product Code: NA Pharmaceutical Form: Capsule, soft INN or Proposed INN: Calcitriol CAS Number: 32222-06-3 Concentration unit: µg microgram(s) Conc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026